The Rest Is Money

2. The drug behind Europe's most valuable company

09.06.2023 - By Goalhanger PodcastsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discovery of the century?

Join Robert and Steph as they answer all these questions and more on today's episode of The Rest Is Money.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

More episodes from The Rest Is Money